Colon-targeted oral delivery is crucial for the treatment of colon-related diseases, as this
delivery strategy enables precise drug administration to the diseased site, enhances drug …

Background: Targeting drug delivery is an attractive research area, as it enables localized
treatment, improves the efficacy of therapeutics and reduces systemic toxicity. Colon …

Nano-drug delivery systems (NDDS) for colon-targeted drug delivery are an active area of
research on local diseases affecting the colon, such as ulcerative colitis, Crohn's disease …

Colon targeted drug delivery is an active area of research for local diseases affecting the
colon, as it improves the efficacy of therapeutics and enables localized treatment, which …

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), is characterized by chronic relapsing inflammation of the gastrointestinal tract. Delivery …

Ulcerative colitis (UC) is a common progressive inflammatory disease whose incidence has
increased rapidly in recent years, and can develop into colorectal cancer in severe cases …

Introduction: Inflammatory bowel disease (IBD) is a chronic relapsing idiopathic disease. In
clinical terms, most patients require lifelong medication associated with possible unpleasant …

Nanoparticles find intriguing applications in oral drug delivery since they present a large
surface area for interactions with the gastrointestinal tract and can be modified in various …

Colorectal cancer (CRC) is a common malignant tumor, and traditional treatments include
surgical resection and radiotherapy. However, local recurrence, distal metastasis, and …

The oral route is a preferred method of drug administration, though achieving effective drug
delivery and minimizing off-target side effects is often challenging. Formulation into …